Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 125 results found. Search for [ Abbreviated New Drug Applications ]

Results 60 to 80 of 125
PTI
October 26, 2018



PTI
October 23, 2018



PTI
October 18, 2018



PTI
October 17, 2018



PTI
October 15, 2018



PTI
October 12, 2018



PTI
October 5, 2018



PTI
October 1, 2018



PTI
May 28, 2018



PTI
May 25, 2018



PTI
May 21, 2018



E. Kumar Sharma
New Delhi, December 11, 2017
Indian pharmaceutical and healthcare companies are on the defensive. Our special report takes you through the headwinds they are facing and how they are reworking the way they make and market medicines.


P.B. Jayakumar
New Delhi, December 11, 2017
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.


BT Online
New Delhi, April 6, 2017
The S&P BSE Sensex ended the day at 29,927.34, down 46.90 points (0.16%) while the Nifty50 ended the day at 9,261.95, down 3.20 points (0.03%).


E. Kumar Sharma
Delhi, April 1, 2017
Leading Indian pharmaceutical companies are facing competition in the US from relatively smaller firms back home.


PTI
New Delhi, December 20, 2016
In a BSE filing, Sun Pharmaceutical Industries said: One of the company's wholly-owned subsidiaries has voluntarily requested the USFDA to withdraw approval for 28 Abbreviated New Drug Applications (ANDAs).


By Joe C. Mathew
Delhi, October 5, 2016
One of the earliest diagnoses made by Sun Pharma in the run-up to the Ranbaxy acquisition was that since the entire management was focusing on resolving the US FDA's negative observations, there was a lack of focus towards expanding the business.


E Kumar Sharma
July 14, 2016
While the product details are not available, analysts feel, if, as the company claims, the products are niche then it could be a differentiator for the company, though again much would depend on the nature of the product pipeline, the stage of development and how close they are to filing for approvals.


PTI
Mumbai, July 7, 2016
Shares of pharma firm Lupin soared over 6 per cent on Thursday after the company received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility, regarding an inspection done by the USFDA in July last year.


PTI
New York, June 22, 2016
A 44-year old Indian-origin hedge fund portfolio manager, who was charged last week with insider trading, has committed suicide in his apartment in New York.


PAGES 4 OF 7  12345